Kiniksa Pharmaceuticals International Plc (KNSA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KNSA Annual Balance Sheets →
Examining balance sheet movements between Kiniksa Pharmaceuticals International Plc and Mar 31 2025 reveals how Mar 31 2026 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent189.95
Short-term Investments, Total278.14
Cash & Short-term Investments467.00
Accounts receivable23.22
Inventories73.14
Prepaid Expense And Other Assets Current29.71
Total Current Assets594.17
Equipment/Property/Plant Net1.99
Intangible Assets15.00
Other Assets, Noncurrent214.12
Deferred Income Tax Assets Net193.63
Total Assets825.28
Liabilities
Accounts Payable, Current AC24.40
Accrued Liabilities, Current AC32.77
Other Liabilities, Current99.44
Total Current Liabilities156.61
Total Long-term Debt0.00
Other liabilities, Noncurrent62.98
Operating Lease Liability Current75.58
Operating Lease Liability Noncurrent5.86
Total Liabilities219.59
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,045.88
Retained Earnings / Accumulated Deficit-439.55
Other Equity-0.66
Common Stockholder's Equity605.69
Total Stockholder's Equity605.69
Liabilities & Stockholder's Equity825.28
4 historic quarters locked

Sign in to unlock the full Kiniksa Pharmaceuticals International Plc balance sheet history.

About Kiniksa Pharmaceuticals International Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-087545

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.